TransCode Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell RNAZ and other ETFs, options, and stocks.About RNAZ
TransCode Therapeutics, Inc. engages in the development and commercializing of diagnostics and therapeutics for the detection and treatment of cancer. The company was founded by Robert Michael Dudley, Zdravka Medarova, and Anna Moore in January 2016 and is headquartered in Boston, MA.
RNAZ Key Statistics
Stock Snapshot
TransCode Therapeutics(RNAZ) stock is priced at $7.03, giving the company a market capitalization of 6.38M. It carries a P/E multiple of -0.03.
On 2025-12-28, TransCode Therapeutics(RNAZ) stock traded between a low of $6.94 and a high of $7.33. Shares are currently priced at $7.03, which is +1.4% above the low and -4.1% below the high.
The TransCode Therapeutics(RNAZ)'s current trading volume is 15.35K, compared to an average daily volume of 13.4K.
During the past year, TransCode Therapeutics(RNAZ) stock moved between $6.15 at its lowest and $468.44 at its peak.
During the past year, TransCode Therapeutics(RNAZ) stock moved between $6.15 at its lowest and $468.44 at its peak.
RNAZ News
Claim 50% Off TipRanks Premium and Invest with Confidence Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper...